The hazard
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN, 46268, USA, NDC 0904-7307-61
- Brand / company
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
- Codes / lots
- Lot #: T05693, Exp. Date 03/2026
- Distribution
- Product was distributed nationwide within the United States.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 27 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.